GenEndeavor LLC
Medtech · Private
Isothermal Chain Reaction (ICR) platform for point-of-care genetic testing assays and diagnostic kits
- Grants
- $1.9M
- 7 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520162017
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Isothermal Chain Reaction (ICR) Detection of SNP Biomarkers for Ovarian Cancer Pont-of-Care Testing and Risk Stratification | $299,998 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Isothermal Chain Reaction ICR Detection of SNP Biomarkers for Ovarian Cancer Pont of Care Testing and Risk Stratification | $349,998 | |
| Federal grant | Department of Health and Human Services · Phase I · Isothermal Chain Reaction (ICR) Rapid and Early Detection of Pathogens for Sepsis Pont-of-Care Testing, Stratification, and Monitoring | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Isothermal Chain Reaction (ICR) Rapid and Early Detection of Pathogens for Sepsis Pont-of-Care Testing, Stratification, and Monitoring | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Rapid and sensitive detection of TB in non-sputum samples and paucibacillary pleural fluid using a novel non-enzymatic isothermal assay platform to enable routine childhood TB screening | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Rapid and sensitive detection of TB in non-sputum samples and paucibacillary pleural fluid using a novel non-enzymatic isothermal assay platform to enable routine childhood TB screening | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Isothermal Chain Reaction (ICR) Detection of SNP Biomarkers for Ovarian Cancer Pont-of-Care Testing and Risk Stratification | $50,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1862 | Saxon Glass Technologies, Inc. | — | — |
| 1863 | VascuLogic LLC | — | — |
| 1864 | HILIGHT SURGICAL, INC. | — | — |
| 1865 | GenEndeavor LLC | — | — |
| 1866 | Critical Link, LLC | — | — |
| 1867 | Qualia, Inc. | — | — |
| 1868 | Minnetronix Medical, Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.